Longitudinal TSPO-PET monitoring of AD patients has revealed that late-stage patients exhibit higher TSPO-PET signals compared to early stages, indicating that skull inflammation persists throughout all stages of AD [39]. The gene discussed is TSPO; the disease is Alzheimer disease.